Last update 04 Nov 2024

Rophibio Co., Ltd

2007|
South Korea
|
rophibio.com

Overview

Tags

Neoplasms
Eye Diseases
Other Diseases
Biosimilar
Monoclonal antibody
Fusion protein

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms6
Immune System Diseases3
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Biosimilar9
Monoclonal antibody7
Fusion protein3
Gene therapy1
Stem cell therapy1
Top 5 TargetCount
PD-1(Programmed cell death protein 1)2
BMP6(Bone morphogenetic protein 6)2
PIGF x VEGF1
CD38(Lymphocyte differentiation antigen CD38)1
GLP-1R(Glucagon-like peptide 1 receptor)1

Related

15
Drugs associated with Rophibio Co., Ltd
RF-G01
Target-
Mechanism-
Active Org.
Rophibio Co., Ltd
Originator Org.
Rophibio Co., Ltd
Active Indication
Neuroblastoma
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
RF-GS03
Target-
Mechanism-
Active Org.
Rophibio Co., Ltd
Originator Org.
Rophibio Co., Ltd
Active Indication
Labyrinth Diseases
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
RF-GS04
Target
BMP6
Mechanism
BMP6 inhibitors
Active Org.
Rophibio Co., Ltd
Originator Org.
Rophibio Co., Ltd
Active Indication
Sjogren's Syndrome
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Rophibio Co., Ltd
NCT06470373 / Not yet recruitingPhase 3
A Phase 3 Clinical Trial to Compare Efficacy, Safety, Tolerability and Immunogenicity of RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration
100 Clinical Results associated with Rophibio Co., Ltd
Login to view more data
0 Patents (Medical) associated with Rophibio Co., Ltd
Login to view more data
100 Deals associated with Rophibio Co., Ltd
Login to view more data
100 Translational Medicine associated with Rophibio Co., Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
11
3
Preclinical
Phase 3
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Aflibercept Biosimilar (Rophibio)
 ( PGF x VEGF-A )		Age Related Macular Degeneration
More
Phase 3
RF-GS04
 ( BMP6 )		Sjogren's Syndrome
More
Preclinical
RF-GS03
Labyrinth Diseases
More
Preclinical
RF-G01
Neuroblastoma
More
Preclinical
RBA-004
 ( STAT3 )		Inflammation
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free